Table of Content
Summary
Pre-IPO funding is back, but it isn't 2021
Crossover rounds collapsed in 2022-23 and reopened in 2026 with tighter anchor structures, staggered lockups, and a new retail wrapper category.
[01]
Anchor terms come with strings now
2026 crossover rounds bundle IPO commitment letters, board observer seats, IPO ratchet protection, and a secondary tender carve-out for employees.
[02]
Lockups are staggered, not flat
2024-2026 IPO lockups release in tranches tied to trading performance: roughly 25 percent at 90 days, 50 percent at 180, balance at 9-12 months.
[03]
Ratchet math you should actually run
Full ratchet versus broad-based weighted average produces very different share counts at a down-IPO. The worked example inside shows both.
[04]
Non-accredited access has a side door
Robinhood Ventures Fund I doubled to $43.69 in 60 days. Retail capital now sits at the pre-IPO table via NYSE-listed closed-end wrappers.
[05]
Most founders treat a pre-IPO funding round in 2026 like a final Series F with a fancier name. They aren't reading the structure right.
The modern crossover round has its own term-sheet architecture, with anchor commitments, IPO ratchet floors, staggered lockups, and a brand-new retail wrapper category sitting next to the institutional pool. Founders who treat it like 2021 are quietly paying for that miscalibration at IPO.
Two recent data points make the shift obvious. Anthropic is reportedly pushing toward a $900B valuation in a round that looks more like a crossover anchor than a traditional Series F. And Robinhood Ventures Fund I, the first NYSE-listed retail wrapper for pre-IPO names like OpenAI, Stripe, and Databricks, doubled from $21 at IPO to $43.69 in roughly 60 days with more than 150,000 retail investors in the book.
Both of those numbers were nearly impossible to imagine in 2023. The pre-IPO market that boomed in 2021 collapsed through 2022-23, dragging Stripe, Klarna, and Instacart through painful down-rounds.
Crossover investors like Tiger and Coatue largely retreated. The late-stage funding window closed.
It reopened in late 2025 and early 2026, with $300B+ in Q1 global startup deal value concentrating into mega-rounds. But the rules changed in three quiet ways: anchor structure, lockup math, and who gets to invest.
After spending years on capital raises at spectup and scouting late-stage secondary deal flow as a venture scout at Flashpoint Venture Capital, my honest take is that founders, late-stage employees, and prospective LPs who treat the 2026 crossover round like the 2021 version are about to learn a fast lesson. Here's how the modern pre-IPO funding round is actually constructed, so you can negotiate, model, or invest in one with your eyes open.
What is pre-IPO funding?
Every late-stage founder I work with asks the same opening question, usually because their lead investor or their CFO has used the term loosely. The label gets applied to anything from a clean Series F to a fully structured crossover round, and the difference matters at term-sheet time.
Pre-IPO funding is a private placement of equity sold by a company in the final 6 to 18 months before its public listing. It's:
Priced at a discount to the expected IPO valuation
Structured to anchor crossover institutional investors who plan to also buy in the IPO
Often pairs with a secondary tender that gives early investors and employees liquidity.
The short answer to what pre-IPO funding in 2026 is is that it's the final private round, but the terms are engineered to support the public offering that follows.
Companies run a pre-IPO funding round for three core reasons in 2026:
Anchor the IPO order book with a crossover fund that has already crossed from private to public participation.
Provide secondary liquidity to early backers and employees who've been waiting years for an exit.
Buy 12 to 18 months of runway if the IPO window is uncertain, without running another scattered Series F or G.
The Anthropic round is the frontier-AI example of reason.
The Stripe employee tender ladder over the past two years is the example of reason.
And the dozens of $1-5B-valuation late-stage companies sitting in the 2026 pipeline that haven't yet picked a listing date are the example of reason.
Those three motivations cover most of what pre-IPO funding is doing on a 2026 cap table, regardless of sector.
This is also why the round came back when most expected the IPO window to open straight into traditional offerings. The IPO calendar has been backed up for three years.
According to Crunchbase data for Q1 2026, global VC hit roughly $297B, with AI absorbing more than 80 percent, and most of that capital concentrated into a handful of frontier AI labs. Those companies need an anchor structure before a public offering.
A standard Series F doesn't deliver one; a pre-IPO crossover round does.
Why did pre-IPO funding rounds collapse in 2022-23, and why did they come back in 2026?
In 2021, the pre-IPO crossover round looked like free money. Tiger Global, Coatue, Sapphire, and a wave of public-equity managers wrote large checks at aggressive valuations on the assumption that an IPO 12-18 months later would mark them up. That assumption broke in 2022.
Stripe re-priced from a roughly $95B internal valuation to a $50B funding round in early 2023.
Klarna and Instacart saw similar resets.
The window for the post-2021 pre-IPO vintage closed before most of those investors could exit through a public offering. Hedge fund participation in late-stage ventures dropped sharply. By mid-2023, the term "crossover investor" had quietly become a euphemism for "stuck".
So, how did pre-IPO funding rounds come back?
Three macro shifts happened:
The late-stage funding freeze pushed companies to need 12-18 month bridges to a more open IPO window.
According to PitchBook's Venture Monitor data, median VC fund close time stretched to 15.3 months, the longest in over a decade, which left late-stage companies short of fresh primary checks from familiar venture LPs.
Secondary markets matured.
Wellington's venture capital outlook projects secondary transactions exceeding $210B in 2025 and staying elevated in 2026, which gave anchors and employees a structural exit valve that didn't exist five years earlier.
Fund finance turned into a $1T market.
As Bloomberg reported in April 2026, that scale of bridge capital makes the long wait between funding and exit financially survivable for institutional holders.
The 2026 version of these pre-IPO funding rounds is a different animal from 2021. The check size looks similar. The architecture underneath is much tighter.
2020-2026 pre-IPO market timeline:
Year | Late-stage market signal | Pre-IPO activity | Dominant investor type |
|---|---|---|---|
2020 | COVID liquidity surge | Crossover rounds growing | Tiger, Coatue, traditional crossovers |
2021 | Peak late-stage valuations | Pre-IPO round count peaks | Hedge funds dominant |
2022 | Public market repricing | Round count falls sharply | Traditional crossovers retreating |
2023 | Down-rounds (Stripe, Klarna) | Pre-IPO round count at multi-year low | Hedge funds largely exit |
2024 | The secondary market formalizes | Secondary tenders rise | Family offices, sovereign wealth |
2025 | Late-stage selectively reopens | Crossover anchors return | Fidelity, T. Rowe, Wellington, Capital Group |
2026 | Frontier-AI IPO pipeline forms | Anchor rounds at $50B+ scale | Crossovers + new retail wrappers (RVI) |
How is a modern pre-IPO crossover round structured?
The 2026 pre-IPO crossover round is a seven-part architecture. I call it the Anchor-Observer-Ratchet (AOR) check when reviewing a term sheet, because those are the three positions where the round is most likely to be mispriced for a founder.
Here's the architecture, top to bottom.
Lead anchor.
Typically a public-equity crossover fund (Fidelity, T. Rowe Price, Wellington, Capital Group, or a sovereign wealth fund). The anchor signs the deal first; everyone else syndicates.
IPO commitment letter.
The anchor agrees to buy a minimum dollar amount in the eventual IPO at market price. This is what makes a crossover round different from a Series F.
The commitment letter is the entire reason the company gives up the next four items.
Board observer rights.
The anchor gets a seat at board meetings, but without a vote. This is how a public-equity manager learns the company before the S-1 lands.
Information rights.
Monthly financials, quarterly board materials, and notice of major events. The anchor needs IC-grade reporting to size the IPO order.
IPO ratchet anti-dilution.
A specific clause that compensates the anchor if the IPO prices below the pre-IPO round. This is the position founders most often misprice. More on the maths below.
Secondary tender carve-out.
A portion of the round (typically 10-25 percent) is structured as a secondary tender for early investors and employees, not new primary capital to the company. This is what makes the round politically possible internally.
ESOP refresh and pro-rata.
Top-up of the employee option pool ahead of the IPO, plus pro-rata rights for the anchor on the next financing or any subsequent secondary.
None of this exists in a clean Series F. The whole point of the crossover round is that the anchor crosses from private to public participation, and the founder pays for that crossing with structural terms. Bain's Global Private Equity Report 2026 framed the institutional-capital pool that now feeds these rounds at scale.
The practical translation is that anchors now expect significantly more structural protection than they did five years ago. For a deeper look at how the document architecture supporting a private placement works in general, our piece on private placement memorandum mechanics walks through the issuer-side disclosure side that underpins any pre-IPO funding round.
The mistake I see most often: a founder treats the crossover round like an IPO without the SEC paperwork. It isn't. It's a private financing with public-market terms layered on top, and the anchor is buying a position in your IPO order book as much as in your equity.
The Anthropic round being structured at frontier AI scale is the public proof point. The same architecture is in play across the smaller $1-5B-valuation pre-IPO candidates, just with smaller checks and faster diligence cycles.
Who actually invests in pre-IPO rounds in 2026?
This is the question I get most often from late-stage founders and from LPs looking at the secondary side:
Who is the realistic anchor for a 2026 pre-IPO funding round?
The investor mix has shifted hard since 2021.
What types of investors lead pre-IPO rounds now?
Traditional asset managers and sovereign wealth funds dominate the lead position.
Hedge funds have a much smaller role than in 2021.
Family offices write meaningful follow-on cheques but rarely anchor. The structurally new category is the NYSE-listed retail venture wrapper.
Here's the comparison table I use when sizing the LP mix on a late-stage mandate.
Investor type | Typical 2026 check | What they negotiate for | Sample 2026 names | IPO commitment willingness | Exit horizon |
|---|---|---|---|---|---|
Crossover funds (asset managers) | $50M-$500M | IPO commitment letter, observer seat, ratchet | Fidelity, T. Rowe Price, Wellington, Capital Group, BlackRock | High | 2-4 years |
Hedge funds | $25M-$200M | Pro-rata, downside protection | Coatue, Tiger (reduced), D1 | Medium | 1-3 years |
Sovereign wealth funds | $100M-$1B+ | Co-investment rights, geographic concessions | PIF, Mubadala, Temasek | Variable | 5+ years |
Family offices | $5M-$50M | Information rights, follow-on access | Single- and multi-family offices | Low | 3-7 years |
Retail venture wrappers (NYSE-listed) | Aggregated pool via public vehicle | No direct negotiation; structural exposure only | Robinhood Ventures Fund I (RVI) | None | Daily liquidity in the wrapper |
The retail wrapper row is the structural change for pre-IPO funding access worth paying attention to. TechCrunch reported on May 11 that Robinhood Ventures Fund I doubled from its $21 IPO open to $43.69 with 150,000+ retail investors, and a second RVI is in preparation. Robinhood's own structure note describes RVI as a publicly traded closed-end fund with daily liquidity, no carry, and a pre-IPO portfolio.
Family offices remain a meaningful follow-on pool. The J.P. Morgan 2026 Global Family Office Report shows that the majority of family offices plan to maintain or increase private market exposure, with private equity allocations near 22 per cent on average.
But they almost never anchor a crossover round; they take the syndicate spot behind a Fidelity or a T. Rowe.
That's the LP mix every pre-IPO term sheet now contends with. Get it wrong, and the round either fails to close or closes with a fragile public-market story.
How does lockup math actually work after a pre-IPO round?
Most articles about pre-IPO lockup period mechanics inside a pre-IPO funding context stop at "180 days". That was correct in 2019. It's no longer correct for the IPOs that priced from 2023 forward.
The modern structure is a staggered waterfall, and it materially changes the math for anyone who took shares in the pre-IPO round or is sitting on employee equity heading into the listing.
Klaviyo, Instacart, Reddit, and ARM all used staggered structures in their 2023-2024 IPOs.
The lockup language sits inside the underwriting agreement and is referenced in the S-1.
You can pull the exact wording from SEC EDGAR filings directly. The Harvard Law School Forum on Corporate Governance walked through the structural shift in 2023 in a piece that has aged well.
Here's the lockup waterfall I model when a client is weighing a secondary tender against holding through the IPO.
2024-2026 typical staggered IPO lockup schedule
Tranche | % of shares | Days post-IPO | Trigger condition | Note |
|---|---|---|---|---|
Tranche 1 | ~25% | 90 days | Stock trades above offer price for 10 of 15 consecutive trading days | Early-release tied to performance |
Tranche 2 | ~25% | 180 days | Standard expiration | The traditional lockup date |
Tranche 3 | ~50% | 270-365 days | Standard expiration, no trigger | Balance of insider holdings |
Underwriter waiver | Variable | Any time | Underwriter discretion | Insiders sometimes released early for diversification |
Founder versus employee lock-up terms are usually not identical.
Founders often hold longer
Senior employees with options sometimes have shorter tranches or accelerated triggers tied to vesting.
The exact split is negotiated round by round.
Here's the practical decision math. A late-stage employee called me a few weeks ago from a Series E company that had just announced a secondary tender at a price 18 percent above his last 409A.
He had to decide between taking the tender at a known number or waiting through the staggered lockup after the planned IPO. We walked through three scenarios: stock trades up 20 percent post-IPO and the 90-day trigger fires; stock trades flat and the first tranche unlocks at 180 days at a similar price; or stock trades down 25 percent and his 90-day trigger never fires, with his 180-day tranche unlocking at a worse price than the tender.
In two of the three scenarios he ends up worse off than the vendor. He took the tender. Math is the new normal.
Ratchet protection: how pre-IPO investors get protected against a down-IPO
This is the clause founders skim and lawyers price. Of every line in a 2026 pre-IPO term sheet, I'd argue the ratchet language moves the most economic value, and the language has tightened sharply since the 2021-22 vintage learnt what a real down-IPO looks like.
Pre-IPO ratchet protection is anti-dilution that compensates the pre-IPO investor if the IPO prices below the round price. There are two main flavours: full ratchet and broad-based weighted average.
The 2021 vintage often had full ratchets. The 2026 vintage usually has a broad-based weighted average plus a specific IPO ratchet trigger with a price floor. The difference is enormous.
Stripe's valuation reset from a $95B internal mark in 2021 to a $50B funding round in March 2023 is the reference case for why this protection exists in pre-IPO term sheets. NVCA's Model Legal Documents contain the authoritative US reference language for anti-dilution provisions, including both full ratchet and broad-based weighted average formulas.
The same anti-dilution logic, in a simpler form, shows up earlier in a startup's life inside the conversion math of convertible notes and SAFE structures. The pre-IPO ratchet is the late-stage cousin of that earlier protection, just with seven more lawyers in the room. I keep that NVCA reference open when reviewing 2026 term sheets because the language is still where most founders lose the most economic value without realising it.
Let me show you the maths. Assume a company runs a pre-IPO round at an $80B post-money valuation, issuing a crossover anchor of $1B for roughly 1.25 percent of the company.
Then the IPO prices at $60B, a 25 percent down-IPO. What does the anchor get back under each ratchet structure?
Worked ratchet math: $1B pre-IPO round at $80B and an IPO at $60B
Structure | Effective purchase price per share adjustment | Anchor ownership before | Anchor ownership after | Practical impact |
|---|---|---|---|---|
No anti-dilution | None | 1.25% | 1.25% | Anchor takes the 25% paper loss |
Broad-based weighted average | Modest price adjustment based on share-count formula | 1.25% | ~1.40-1.50% | Anchor is partially compensated; other shareholders dilute moderately |
Full ratchet | Effective price reset to IPO price | 1.25% | ~1.67% | Anchor is fully compensated; founders and employees absorb the dilution |
Full ratchet with 10% floor | Reset capped at 10% below round price | 1.25% | ~1.39% | Compromise structure; common in 2026 |
I'll say what most articles on this topic won't: a founder who signs a pure full ratcheting in a 2026 pre-IPO funding round without a floor is taking a meaningful risk that the IPO market doesn't behave. The 2021 vintage paid for that mistake.
The 2026 vintage is mostly negotiating the floor right now, which is the sensible compromise. From the late-stage secondary deal flow I see, the broad-based weighted average plus IPO ratchet floor structure is becoming the default for institutional anchors.
The valuation is the headline. The ratchet is where the money actually moves. Most founders negotiate the headline and accept the lawyer language underneath, and most of them only learn what they signed when the IPO prices below the round.
The non-accredited investor pre-IPO access question
The short answer is 'Directly, almost never; indirectly, in 2026, yes.' US Reg D 506(b) and 506(c) limit primary pre-IPO funding placements to accredited investors. The SEC's accredited investor definition sets the $200K income / $1M net worth thresholds that have governed direct private-placement access for decades, which is the central constraint behind every non-accredited investor pre-IPO question.
What changed in 2026 is the structural side door. There are now three meaningful routes for non-accredited retail capital to reach pre-IPO funding names without satisfying the accreditation thresholds directly.
NYSE-listed retail venture wrappers.
Robinhood Ventures Fund I (RVI) is the first scaled example. RVI is a publicly traded closed-end fund holding a pre-IPO portfolio with names like OpenAI, Stripe, Databricks, and Oura. Any retail broking account can buy shares of RVI.
A second RVI is reportedly in preparation. This is the largest structural shift in retail pre-IPO access in a decade.
Secondary marketplaces (US accredited only).
EquityZen, Forge, and Hiive run secondary marketplaces in pre-IPO names, but all three still gate primary access by US accreditation. The wrapper route bypasses that wall; the marketplace route doesn't.
Reg CF (Title III crowdfunding).
Companies can raise up to roughly $5M per year from non-accredited investors via Reg CF. In practice, almost no pre-IPO-scale company uses this; it's a meaningful route for earlier-stage rounds, not late-stage private placements.
Outside the US, the rules are different. For pre-IPO funding in Australia, the relevant framework is the Corporations Act section 708 sophisticated and professional investor exceptions, administered by ASIC.
ASIC's guidance on sophisticated-investor certificates sets the thresholds (broadly, net assets of A$2.5M or gross income of A$250K for two consecutive years).
Australian retail investors who don't qualify can still get pre-IPO exposure indirectly via ASX-listed LICs (listed investment companies) and ESVCLP-structured funds.
That's the practical answer to how pre-IPO investing works for Australian retail.
The structural translation: pre-IPO funding Australia has its own version of the wrapper route, just with different regulatory wiring. The same logic applies in the UK and Singapore, but Australia's framework is the cleanest non-US comparison because the sophisticated-investor test is well documented and the ASX-listed LIC market is deep enough to actually clear retail demand. Founders running a pre-IPO funding Australia process for an Australian-domiciled company should map their cap table against both S708 thresholds and the ASX-listed LIC pool before signing the term sheet.
Pre-IPO access route comparison
Investor profile | Direct primary access | Wrapper access | Minimum check | Liquidity |
|---|---|---|---|---|
US accredited individual | Yes, via 506(b)/(c) | Yes (RVI, marketplaces) | $10K-$100K direct, ~$22 RVI share | Illiquid direct, daily on wrapper |
US non-accredited individual | No (except Reg CF) | Yes (RVI only) | ~$22 RVI share | Daily on wrapper |
Australian sophisticated investor | Yes via s708 exception | Yes (LICs, ESVCLPs) | Varies by structure | Quarterly to daily |
Australian retail investor | No | Yes (ASX-listed LICs) | Per ASX share | Daily on ASX |
This is the section where the 2026 story departs hardest from prior years. Two years ago, retail capital had no real path into a pre-IPO name short of waiting for the post-IPO listing.
Today, an ordinary brokerage account can hold a position in OpenAI through RVI. The accreditation wall has a side door, and the size of the door is going to keep growing as second-mover wrappers list. For any non accredited investor pre ipo conversation in 2026, the wrapper route is now the default answer rather than the exception.
When should founders actually run a pre-IPO funding round?
This is the founder-side decision. Every advisor will tell you the upside of a crossover anchor; few will be honest about when the round doesn't pencil.
After working with late-stage founders, my read is that there are three legitimate reasons to run a pre-IPO funding round and three that look legitimate but usually aren't. The deeper question, how does pre-IPO investing work for the founder rather than the anchor, comes down to whether the anchor terms actually buy you something an alternative structure wouldn't.
Legitimate reasons. First, you need an anchor in your IPO book, and a credible crossover relationship is the only way to get one.
Second, your early investors and employees actually need secondary liquidity before the IPO process consumes the next 12-18 months, and a tender carve-out is the cleanest way to deliver it.
Third, the IPO window is uncertain and you need 12-18 months of additional runway with an investor who'll still be there at the public offering.
Reasons that look legitimate but usually aren't. First, re-marking the valuation upward to reset comp expectations.
The cap table reads the round, the employees read the round, and you've just compressed your IPO valuation window. Second, creating a paper milestone for fundraising PR. Crossover investors are sophisticated enough to flag a vanity round before they sign.
Third, avoiding the rigour of public-market diligence. The anchor is going to ask for everything an underwriter asks for and then some, and they'll have observer rights to keep asking.
A founder of a $1.5B-valuation company asked me last quarter whether to run a pre-IPO crossover round or go straight into a dual-track IPO plus strategic sale process. We walked through the framework below, paying particular attention to whether a pre-IPO secondary tender offer would also be needed to clear employee liquidity in parallel.
The pre-IPO crossover round only made sense for situation 1 (anchor pull-through) and situation 3 (runway bridge). For everything else, the dual-track structure was cleaner, faster, and gave less up. Crunchbase's 2026 IPO watch list includes companies like Cohere at roughly $7B with $150M ARR and Canva at $42B with $3.3B annualised that are exactly the profile facing this same call.
Pre-IPO round decision matrix
Founder situation | Run pre-IPO round? | Preferred structure, if yes | Alternative if no |
|---|---|---|---|
Need IPO anchor pull-through | Yes | Crossover anchor + IPO commitment letter | Wait for traditional IPO bookrunner allocation |
Employees need liquidity | Yes | Secondary tender carve-out within crossover round | Standalone secondary tender on Forge/EquityZen |
Need 12-18 month runway bridge | Depends | Crossover + ratchet floor | Traditional Series F or venture debt |
Want to re-mark valuation up | No | N/A | Focus on operating metrics |
Want a fundraising PR milestone | No | N/A | Skip the round entirely |
Want to avoid public-market diligence | No | N/A | Either go public or stay private |
Across the recent late-stage mandates I've worked on at spectup, the rough pattern is that the founders who choose the pre-IPO round only proceed when they have at least one of the three legitimate reasons backed by a concrete operational need, not a strategic narrative.
My honest read on the 2026 pre-IPO funding market
I think the conventional advisory framing on pre ipo funding is missing what's actually changed. Most of the public commentary treats the 2026 reopening as the 2021 boom returning, which gets the story exactly wrong.
The cheque sizes look similar, but the structural cost a founder pays for those cheques is much higher, and the LP pool feeding the rounds has reorganised around traditional asset managers plus a new retail wrapper category that nobody priced into 2021's playbook.
The contrarian take I'd offer founders:
A crossover round is a private financing with public-market terms layered on top
You're paying for an IPO commitment letter, an observer seat, and a ratchet floor with structural concessions.
Calling it "an IPO without the SEC paperwork" hides the price.
If the only reason to run the round is anchor pull-through, the trade is usually worth it.
If any of the other reasons are driving the decision, you're probably better off either going straight to the IPO or staying private with a clean secondary tender.
The companies that overpay for crossover anchors in 2026 are going to be the ones whose founders thought of it as a friendlier IPO. The ones that pay fairly are the ones that thought of it as a public-market relationship that starts in private and continues into the listing. Those are two different mental models, and they price the same round very differently.
The 2022-23 reset taught crossover investors that public-market discipline applies to private investments. The 2026 vintage reflects that.
The founders who internalise the same lesson and negotiate accordingly are going to be the ones whose rounds actually price into successful IPOs. The ones who don't are going to relearn the Stripe lesson under their own names.
One unfashionable view I hold is that the retail wrapper category is the most important structural development in pre-IPO funding in a decade, and it's going to keep mattering. The wrapper structure forces a kind of pricing transparency on names that previously traded only in dark secondary marketplaces, even though the retail capital underneath it isn't necessarily smart capital.
RVI doubling in 60 days is partly an AI rally story, but it's also a signal that there's significant retail demand for private-market exposure that the accredited-only structure has been suppressing for years.
I sat with a founder who had an IPO of his startup. Watch this podcast and you will learn about the amazing journey that was driven by IPO and building great products
How spectup helps late-stage founders run a pre-IPO funding round
Most of what shows up in a pre-IPO funding term sheet has been negotiated three times before by the anchor's legal team. The founder sees it once.
That asymmetry is the real source of value loss in 2026 crossover rounds, and it's where we focus when we run a late-stage pre-IPO funding mandate. We model the ratchet math, pressure-test the IPO commitment letter language, structure the secondary tender carve-out, and run the investor outreach to keep the anchor honest on terms. The pre-IPO valuation structure work is where most of the negotiable economic value actually sits.
On the LP side, family offices and growth-stage funds that want exposure to pre-IPO names without the wrapper discount benefit from sourcing into syndicate positions behind a credible lead anchor. We keep a working pre-IPO investors list of crossover funds, sovereign wealth allocators, and growth-stage hedge funds that have actually written a 2026 anchor cheque, which is how that sourcing work translates from a pitch into a real allocation. That sourcing work is what a real private placement agent does at this stage of the market.
The other half of the work is the financial model that supports the round: anchor sizing, lockup waterfall scenarios, and ratchet outcomes across IPO valuation scenarios. That's why our financial modeling consultant practice sits alongside the deck and outreach side of every late-stage mandate.
If you're a founder weighing a pre-IPO funding round or an LP evaluating a syndicate position, we can walk through the structure with you on a call.
Where I'd actually focus right now on pre-IPO funding
If I had to give one piece of advice to a founder reading this in May 2026, it would be to stop benchmarking your pre-IPO funding round against 2021 and start benchmarking it against 2026. The Anthropic round, the Stripe employee tenders, the RVI listing, and the staggered Klaviyo and Reddit lockups – these are the current comparables. Anything older is rhetorical, not structural.
If I had to give one to an LP, it would be: don't anchor a crossover position without an IPO commitment letter that you'd actually commit to. The whole point of a pre ipo crossover round is the public-market crossing. A check without the letter is a Series F in formal clothing, and you'll pay a premium for the costume.
And the unresolved question for the rest of 2026 is whether the retail wrapper category scales fast enough to change the syndicate math on later anchor rounds. If a second RVI lists at scale and a third follows, the pre-IPO funding market will look meaningfully different by Q4. That's not a prediction; it's the open question I'd watch.
The next pre-IPO funding round you participate in or run will be priced either off the right comparables or the wrong ones. Pick the right ones, and the round works. Pick the wrong ones and you'll learn what 2026 actually meant after the IPO prices.
Concise Recap: Key Insights
Crossover rounds returned with strings attached
IPO commitment letters and board observer seats are now standard in 2026 pre-IPO terms. Anchor check size alone no longer wins the round; structural alignment does.
Lockup math runs staggered, not flat
Modern 2024-2026 IPO lockups release in tranches tied to trading performance. Plan exit math around the waterfall and price triggers, not a single 180-day date.
Non-accredited access opened quietly
Robinhood Ventures Fund I doubled in 60 days. Retail capital now sits at the pre-IPO table via NYSE-listed closed-end wrappers; expect more wrappers to list.
Frequently Asked Questions
What is pre-IPO funding?
Pre-IPO funding is a private placement of equity sold by a company in the final 6 to 18 months before its public listing. It's typically priced at a discount to the expected IPO valuation, structured to anchor crossover institutional investors who help support the IPO book, and often pairs with a secondary tender that provides early-investor and employee liquidity.
